- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07658963
First Step Program for Substance Use Disorders
A Preliminary Study on the Effectiveness of a Psychosocial Treatment Program (First Step Program) for Substance Use Disorders
This study examines whether a newly developed four-session psychosocial treatment program, called the First Step Program, can be delivered in real-world hospital settings to people receiving inpatient care for substance use disorders in Korea, and whether it shows early signs of benefit. The program combines motivational interviewing, acceptance and commitment therapy, and group activities, and is delivered twice a week over about two weeks (four 50-minute sessions). About 20 adults will take part at two psychiatric hospitals.
Participants complete brief questionnaires and a short interview about their motivation to change, craving, engagement in valued living, and social support before the program, immediately before and after each session, within one week after the program ends, and again at 1 month and 3 months after completion. After the program, some participants also join a small group discussion (focus group interview) to share their experience of the program.
Because this is a small, single-group preliminary (pilot) study without a comparison group, its primary purpose is to assess feasibility, that is, whether the program and the assessment approach work well enough, and to obtain preliminary effect and variability estimates to inform the design of a future large-scale randomized controlled trial.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Background: Substance use among the Korean population has increased rapidly, yet standardized, evidence-based psychosocial treatment programs and a corresponding clinician training and certification system are not well established in Korea. Evidence-based psychosocial interventions such as cognitive behavioral therapy, motivational interviewing, community reinforcement approaches, and 12-step facilitation are widely used as standard care in other countries, but comparable, locally validated programs are scarce in Korea. To address this gap, a Korean psychosocial treatment program (the First Step Program) was developed, and this preliminary study evaluates its feasibility and preliminary effectiveness.
Objectives:
- Primary objective: to evaluate the real-world feasibility of delivering the First Step Program to inpatients with substance use disorders.
- Secondary objective: to examine preliminary changes in motivation to change (URICA-DO), craving (VAS-C), engaged living (Engaged Living Scale), social support (2-Way Social Support Scale), and drug use history and treatment service utilization, and to assess whether these measures are suitable for a future comparative trial.
- Tertiary objective: to explore participants' subjective experience and the acceptability of the program through a focus group interview, in order to refine the treatment manual and operational protocol for a future randomized controlled trial.
Design and setting: This is a single-arm, pre-post study with follow-up, without a control group. A total of 20 participants (10 per site) will be enrolled at two psychiatric hospitals that provide care to a large proportion of patients with drug use disorders in Korea (Incheon Chamsarang Hospital and Daegu Daedong Hospital). Study planning, rater training, informed consent storage, data management, and statistical analysis are coordinated centrally by the Catholic University of Korea. The two participating sites do not have their own IRB and are reviewed under the Uijeongbu St. Mary's Hospital IRB.
Intervention: The First Step Program consists of four 50-minute group sessions delivered twice weekly. The program integrates motivational interviewing, acceptance and commitment therapy, and group therapy. Session themes are: (1) treatment, choice, and personal values; (2) understanding the function of substance use and imagining alternative paths; (3) ambivalence and recovery-supporting relationships; and (4) charting a recovery direction and declaring a personal recovery plan.
Assessment schedule: Baseline assessment occurs within one week before the program. Craving is assessed immediately before and after each session, along with a stage-of-change rating, session satisfaction, and a treatment fidelity self-assessment. Post-intervention assessment occurs within one week after the program, followed by a focus group interview. Follow-up assessments are conducted at 1 month and 3 months after program completion.
Statistical analysis: Feasibility will be summarized using recruitment, retention, session attendance, and assessment completion rates. Change in continuous outcomes over time (pre, post, follow-up) will be analyzed using paired t-tests and linear mixed models; binary outcomes will be analyzed using McNemar's test and, where covariate adjustment for repeated measures is needed, generalized estimating equations. Missing data judged to be MCAR/MAR will be handled via maximum likelihood estimation within linear mixed models or multiple imputation, with sensitivity analyses. The main analysis is based on the full analysis set, with the per-protocol set as a supportive analysis. Qualitative focus group data will be transcribed and analyzed using thematic analysis (Braun & Clarke, 2006) by at least two independent coders.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Hae Kook Lee, MD, PhD
- Número de teléfono: +82-31-820-3050
- Correo electrónico: policyhklee@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Hae-Ryoung Chun, PhD
- Número de teléfono: +82-10-6567-7833
- Correo electrónico: mamimihae@catholic.ac.kr
Ubicaciones de estudio
-
-
-
Daegu, Corea del Sur
- Daegu Daedong Hospital
-
Contacto:
- Do-Hoon Kwon, MD, PhD
- Número de teléfono: +82-53-663-1634
- Correo electrónico: dohoonkwon@hotmail.com
-
Incheon, Corea del Sur
- Incheon Chamsarang Hospital
-
Contacto:
- Younghoon Chon, MD, PhD
- Número de teléfono: +82-32-571-9111
- Correo electrónico: 8542231@daum.net
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Adults aged 19 to 65 years who can understand the study purpose and procedures and provide written informed consent
- Currently hospitalized (inpatient)
- Able to communicate and complete questionnaires in Korean
- Physically able to participate in program activities
- Has completed detoxification treatment
- Meets indication thresholds: DAST-10 score >= 2, URICA-DO precontemplation or contemplation stage, and >= 2 DSM-5 criteria
Exclusion Criteria:
- Cognitive impairment that precludes communication
- Physical conditions that preclude program participation (e.g., musculoskeletal disorder, severe cardiopulmonary disease)
- Acute psychotic symptoms or risk of self-harm or harm to others
- At risk of disrupting group activities such that focus group participation is not feasible
- Individuals who are inmates or incarcerated at screening are not enrolled; participants who become incarcerated after enrollment are withdrawn
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: First Step Program
All participants receive the First Step Program, a four-session group-based psychosocial treatment delivered twice weekly (50 minutes per session) over approximately two weeks.
The program integrates motivational interviewing, acceptance and commitment therapy, and group therapy, covering values clarification, functional analysis of substance use, ambivalence and recovery-supporting relationships, and a personalized recovery plan.
|
Four 50-minute group sessions delivered twice weekly over approximately two weeks.
Session 1: treatment, choice, and personal values.
Session 2: understanding the function of substance use and exploring alternative behaviors.
Session 3: addressing ambivalence and recovery-supporting relationships.
Session 4: charting a recovery direction and declaring a personal recovery plan.
Core techniques are motivational interviewing, acceptance and commitment therapy, and group therapy.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Feasibility: Program Completion (Retention) Rate
Periodo de tiempo: From enrollment through the end of the 4-session intervention (approximately 2 weeks)
|
Proportion of enrolled participants who complete all four sessions of the First Step Program.
Feasibility is further characterized by recruitment rate, session attendance, and assessment completion rates.
|
From enrollment through the end of the 4-session intervention (approximately 2 weeks)
|
|
Change in Motivation to Change (URICA-DO)
Periodo de tiempo: Baseline (within 1 week before program), post-intervention (within 1 week after program), 1 month and 3 months after program completion
|
Motivation to change (readiness) measured by the Korean version of the University of Rhode Island Change Assessment for Drug Offenders (URICA-DO), a 24-item scale rated from 1 (strongly disagree) to 5 (strongly agree) with four subscales (Precontemplation, Contemplation, Action, Maintenance).
A Readiness to Change score is computed as the sum of the mean Contemplation, Action, and Maintenance subscale scores minus the mean Precontemplation subscale score, yielding a range of -2 to 14; higher scores indicate greater readiness to change (better outcome).
|
Baseline (within 1 week before program), post-intervention (within 1 week after program), 1 month and 3 months after program completion
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Craving (VAS-C)
Periodo de tiempo: Immediately before and immediately after each of the 4 sessions (over approximately 2 weeks); baseline (within 1 week before the program); within 1 week post-intervention; 1 month post-intervention; 3 months post-intervention
|
Craving measured by the Visual Analog Scale for Craving (VAS-C), ranging from 0 to 100 mm (0 = no craving, 100 = constant craving); higher scores indicate greater craving (worse outcome).
|
Immediately before and immediately after each of the 4 sessions (over approximately 2 weeks); baseline (within 1 week before the program); within 1 week post-intervention; 1 month post-intervention; 3 months post-intervention
|
|
Change in Engaged Living (Engaged Living Scale, ELS)
Periodo de tiempo: Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
|
Engagement in valued living measured by the Engaged Living Scale (ELS), a 16-item scale rated from 1 to 5 (total range 16 to 80); higher scores indicate greater engagement in valued living (better outcome).
|
Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
|
|
Change in Social Support (2-Way Social Support Scale)
Periodo de tiempo: Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
|
Perceived social support measured by the 2-Way Social Support Scale (2-Way SSS), a 19-item scale rated from 1 to 5 (total range 19 to 95) covering received and provided support; higher scores indicate greater social support (better outcome).
|
Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
|
|
Change in Drug Use and Treatment Service Utilization
Periodo de tiempo: Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
|
Self-reported drug use history and treatment service utilization assessed via a structured 1:1 interview.
Recall window is the past 30 days at most time points and the past 2 months at the 3-month follow-up.
|
Baseline, post-intervention (within 1 week), 1 month and 3 months after completion
|
|
Program Acceptability (Focus Group Interview)
Periodo de tiempo: Within 1 week after program completion
|
Acceptability and subjective experience of the program explored through a focus group interview using a semi-structured guide, analyzed by thematic analysis.
|
Within 1 week after program completion
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Stage of Change Rating per Session
Periodo de tiempo: Immediately after each of the 4 sessions (over approximately 2 weeks)
|
Readiness for treatment engagement rated on a visual analog scale from 0 to 100 mm (0 = participating reluctantly, 100 = ready to participate actively); higher scores indicate greater readiness (better outcome).
|
Immediately after each of the 4 sessions (over approximately 2 weeks)
|
|
Session Satisfaction
Periodo de tiempo: Immediately after each of the 4 sessions
|
Participant-rated helpfulness of each session on a visual analog scale from 0 to 100 mm (0 = not helpful at all, 100 = very helpful); higher scores indicate greater satisfaction (better outcome).
|
Immediately after each of the 4 sessions
|
|
Treatment Fidelity (Adherence Rate)
Periodo de tiempo: Immediately after each of the 4 sessions
|
Therapist self-assessed treatment fidelity comprising structural fidelity and clinical-process fidelity items (yes/no), summarized as an adherence rate per session and per therapist.
|
Immediately after each of the 4 sessions
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Hae Kook Lee, MD, PhD, The Catholic University of Korea
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- UC26FIDI0017
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre First Step Program
-
PlenOptika, Inc.National Eye Institute (NEI); New England College of OptometryTerminadoErrores refractivosEstados Unidos
-
Yonsei UniversityAún no reclutandoMasa mediastínica que requiere escisión quirúrgica asistida por videoCorea, república de
-
NYU Langone HealthRetirado
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)TerminadoTrastorno de ansiedadCanadá
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)TerminadoCáncer | Insomnio | Insomnio debido a una condición médicaEstados Unidos
-
CooperVision, Inc.Terminado
-
Oregon Health and Science UniversityTexas A&M University; University of North Carolina, GreensboroActivo, no reclutandoActividad físicaEstados Unidos
-
The AlfredMonash UniversityTerminadoFibrosis | Enfermedades pulmonares | Enfermedades pancreáticas | Fibrosis quística | Enfermedades genéticas | Enfermedades respiratoriasAustralia
-
Children's HealthTerminadoDesorden del espectro autistaEstados Unidos
-
The University of Hong KongSydney Children's Hospitals Network; SAHKTerminadoDesorden del espectro autistaHong Kong